Published in Hum Hered on January 17, 2007
Convergent genetic linkage and associations to language, speech and reading measures in families of probands with Specific Language Impairment. J Neurodev Disord (2009) 1.57
Genetic advances in the study of speech and language disorders. Neuron (2010) 1.33
The genetics of reading disabilities: from phenotypes to candidate genes. Front Psychol (2013) 1.12
The complex of TFII-I, PARP1, and SFPQ proteins regulates the DYX1C1 gene implicated in neuronal migration and dyslexia. FASEB J (2008) 1.06
Pleiotropic effects of DCDC2 and DYX1C1 genes on language and mathematics traits in nuclear families of developmental dyslexia. Behav Genet (2010) 0.93
Motor sequencing deficit as an endophenotype of speech sound disorder: a genome-wide linkage analysis in a multigenerational family. Psychiatr Genet (2012) 0.88
Speaking genes or genes for speaking? Deciphering the genetics of speech and language. J Child Psychol Psychiatry (2009) 0.88
Children with comorbid speech sound disorder and specific language impairment are at increased risk for attention-deficit/hyperactivity disorder. J Abnorm Child Psychol (2007) 0.87
Literacy outcomes of children with early childhood speech sound disorders: impact of endophenotypes. J Speech Lang Hear Res (2011) 0.87
A multigenerational family study of oral and hand motor sequencing ability provides evidence for a familial speech sound disorder subtype. Top Lang Disord (2011) 0.85
Etiologies and molecular mechanisms of communication disorders. J Dev Behav Pediatr (2010) 0.81
A common haplotype of KIAA0319 contributes to the phonological awareness skill in Chinese children. Behav Brain Funct (2014) 0.78
Association between AVPR1A, DRD2, and ASPM and endophenotypes of communication disorders. Psychiatr Genet (2014) 0.76
Non-nuclear Pool of Splicing Factor SFPQ Regulates Axonal Transcripts Required for Normal Motor Development. Neuron (2017) 0.75
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) (1988) 7.02
Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br Med J (Clin Res Ed) (1987) 5.01
Unicellular cyanobacteria fix N2 in the subtropical North Pacific Ocean. Nature (2001) 4.77
School-age outcomes in children with birth weights under 750 g. N Engl J Med (1994) 3.74
Structural relationships among Rhizobium meliloti symbiotic promoters. Cell (1983) 3.23
The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10
Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol (2000) 3.05
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J Clin Oncol (1992) 3.00
Interaction between transcription factors Sp1 and YY1. Nature (1993) 2.87
Cytogenetic analysis of a segment of the Y chromosome of Drosophila melanogaster. Genetics (1984) 2.75
On the structural diversity of fern antheridiogens. Naturwissenschaften (1972) 2.47
Cimetidine and HDL cholesterol. Lancet (1983) 2.40
Statistical evidence for miscoding lesions in ancient DNA templates. Mol Biol Evol (2001) 2.39
Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr (1996) 2.26
Performance-based physician reimbursement and influenza immunization rates in the elderly. The Primary-Care Physicians of Monroe County. Am J Prev Med (1998) 2.23
Long-term developmental outcomes of low birth weight infants. Future Child (1995) 2.23
Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta (1976) 2.19
Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16
Cutaneous hypersensitivity following peripheral tissue damage in newborn infants and its reversal with topical anaesthesia. Pain (1989) 2.12
How best to estimate the global burden of pertussis? Lancet Infect Dis (2003) 2.08
Estimating the global burden of foodborne diseases--a collaborative effort. Euro Surveill (2009) 2.01
Reducing the risks of coronary heart disease in individuals and in the population. Lancet (1986) 1.95
Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest (1966) 1.88
Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J (1992) 1.88
Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol (1983) 1.86
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest (1975) 1.82
Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) (1981) 1.80
The modernization of Asia. Implications for coronary heart disease. Council on Arteriosclerosis of the International Society and Federation of Cardiology. Circulation (1996) 1.76
Epidemic perinatal listeriosis. Pediatr Infect Dis (1984) 1.74
Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern Med (2000) 1.71
Pain control in inflammation governed by selectins. Nat Med (1998) 1.65
CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell (2000) 1.63
A prospective outcome study of patients with clot in an ulcer and the effect of irrigation. Gastrointest Endosc (1996) 1.62
Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet (1981) 1.61
Myocardial contrast echocardiography yields best accuracy using quantitative analysis of digital data from pulse inversion technique: comparison with second harmonic imaging and harmonic power Doppler during simultaneous dipyridamole stress SPECT studies. Eur J Echocardiogr (2002) 1.61
Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke (2004) 1.59
Subcutaneous crystal-storing histiocytosis associated with lymphoplasmacytic lymphoma (immunocytoma) Pathol Res Pract (1996) 1.57
Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest (1980) 1.55
Preinjury family environment as a determinant of recovery from traumatic brain injuries in school-age children. J Int Neuropsychol Soc (1997) 1.54
Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices. Gastroenterology (1996) 1.51
Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing "optimal" dosing. Am J Gastroenterol (1995) 1.51
Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ (1995) 1.50
Converting venous acid-base and oxygen status to arterial in patients with lung disease. Eur Respir J (2009) 1.50
Serum bile acids in liver disease. Gut (1971) 1.50
Peripheral morphine analgesia. Pain (1997) 1.49
Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res (1990) 1.48
Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience (1992) 1.48
Distribution and characterization of canine Chagas disease in Texas. Vet Parasitol (2008) 1.48
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res (1975) 1.47
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther (2007) 1.45
Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci (1995) 1.45
[Opioid therapy in chronic non-malignant pain]. Anaesthesist (2003) 1.44
Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut (2005) 1.43
Distribution of vaccine/antivirals and the 'least spread line' in a stratified population. J R Soc Interface (2009) 1.42
Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol (1996) 1.42
Family burden and adaptation during the initial year after traumatic brain injury in children. Pediatrics (1998) 1.41
Pre-hospital rapid sequence induction: factual inaccuracies. S Afr Med J (2013) 1.40
[Involuntary diurnal urinary incontinence among children--is it curable?]. Ugeskr Laeger (1996) 1.39
[Pitfalls in hypertension management--misjudgements in diagnosis and therapy]. Dtsch Med Wochenschr (2002) 1.39
[Phlegmasia cerulea dolens--a severe complication of a frequent disease]. MMW Fortschr Med (2009) 1.38
Pit viper bites: rational management in locales in which copperheads and cottonmouths predominate. Ann Plast Surg (1996) 1.38
Nonsteroidal antiinflammatory agents. I. 6-substituted 2-naphthylacetic acids. J Med Chem (1970) 1.38
Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa. Immunobiology (1997) 1.37
Psychiatric training for family doctors: what do GP registrars want and can a brief course provide this? Med Educ (1999) 1.37
Differences in body composition of black and white girls. Am J Clin Nutr (1996) 1.36
Involvement of the GTP binding protein Rho in constitutive endocytosis in Xenopus laevis oocytes. J Cell Biol (1995) 1.36
Glucose transporter function is controlled by transporter oligomeric structure. A single, intramolecular disulfide promotes GLUT1 tetramerization. Biochemistry (1995) 1.35
Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry. Ann Rheum Dis (2008) 1.33
Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia. Eur J Clin Invest (1980) 1.32
Will the government's mass media campaign on drugs work? Br Med J (Clin Res Ed) (1985) 1.31
Serum-bile-acids in the stagnant-loop syndrome. Lancet (1969) 1.30
Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience (1993) 1.29
Differential synthesis in vitro of barley aleurone and starchy endosperm proteins. Plant Physiol (1986) 1.28
Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest (1997) 1.27
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm (Vienna) (2004) 1.26
Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease. Arterioscler Thromb Vasc Biol (1999) 1.26
Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol (1995) 1.25
Accident and emergency: why patients choose A and E. Health Soc Serv J (1981) 1.25
Muscle strength as a predictor of bone mineral density in young women. J Bone Miner Res (1990) 1.24
Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial. Lancet (1983) 1.24
How to develop and use a patient questionnaire. Physicians Manage (1986) 1.24
Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr Top Microbiol Immunol (1988) 1.22
Hyperalgesia in premature infants. Lancet (1988) 1.22
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease. Gut (2004) 1.21
Academic achievement in high functioning autistic individuals. J Clin Exp Neuropsychol (1994) 1.21
Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology (2001) 1.21
Studies in the metabolism of cholesterol in subjects with normal plasma cholesterol levels and in patients with essential hypercholesterolaemia. Clin Sci (1967) 1.20
Thyroid function in coronary-artery disease. Lancet (1971) 1.20
Coronary artery reperfusion in acute myocardial infarction: beneficial effects of intracoronary streptokinase on left ventricular salvage and performance. Am Heart J (1981) 1.20
Prevalence of ischaemic heart disease and associations with serum lipoproteins in subjects aged 45 to 64 years. The Speedwell study. Br Heart J (1982) 1.19
Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol (1985) 1.19
Pain and the immune system. Br J Anaesth (2008) 1.18
Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J Neurosurg (1997) 1.18
Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer. Exp Neurol (1999) 1.18
Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. Br Med J (1973) 1.17